91
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data

, , , , , & show all
Pages 93-101 | Published online: 12 Jan 2016

References

  • GibsonGJLoddenkemperRSibilleYLundbäckBFletcherMEuropean Respiratory Society. European Lung White Book2013 Available from: www.erswhitebook.orgAccessed March 12, 2015
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for Diagnosis, Management and Prevention of COPD2014 Available from: www.goldcopd.comAccessed January 12, 2015
  • RobertsSDFarberMDKnoxKSFEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of ageChest2006130120020616840402
  • CarolanBJSutherlandERClinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advancesJ Allergy Clin Immunol2013131362763423360757
  • BujarskiSParulekarADSharafkhanehAHananiaNAThe asthma COPD overlap syndrome (ACOS)Curr Allergy Asthma Rep201515350925712010
  • DecramerMSelroosOAsthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseasesInt J Clin Pract200559438539815853852
  • PostmaDSReddelHKten HackenNHvan den BergeMAsthma and chronic obstructive pulmonary disease: similarities and differencesClin Chest Med201435114315624507842
  • TashkinDPCelliBDecramerMBronchodilator responsiveness in patients with COPDEur Respir J200831474275018256071
  • CalverleyPMAlbertPWalkerPPBronchodilator reversibility in chronic obstructive pulmonary disease: use and limitationsLancet Respir Med20131756457324461617
  • O’ReillyJJonesMMParnhamJLovibondKRudolfMManagement of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidanceBMJ2010340c313420581031
  • LouieSZekiAASchivoMChanALYonedaKYAvdalovicMThe asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerationsExpert Rev Clin Pharmacol20136219721923473596
  • MelaniASBonaviaMCilentiVInhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med2011105693093821367593
  • LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthmaRespir Med2008102459360418083019
  • ChrystynHPriceDNot all asthma inhalers are the same: factors to consider when prescribing an inhalerPrim Care Respir J200918424324919513494
  • DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
  • BrocklebankDRamFWrightJComparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literatureHealth Technol Assess2001526114911701099
  • SchulteMOsseiranKBetzRHandling of and preferences for available dry powder inhaler systems by patients with asthma and COPDJ Aerosol Med Pulm Drug Deliv200821432132818823257
  • ChrystynHCloser to an “ideal inhaler” with the Easyhaler®. An innovative dry powder inhalerClin Drug Invest2006264175183
  • ChrystynHHaahtelaTReal-life inhalation therapy–inhaler performance and patient education matterEur Respir Dis201281118
  • American Thoracic SocietyStandardization of spirometry. 1994 updateAm J Respir Crit Care Med19951523110711367663792
  • KauppiPKupiainenHLindqvistAOverlap syndrome of asthma and COPD predicts low quality of lifeJ Asthma201148327928521323613
  • AndersenHLampelaPNevanlinnaASaynajakangasOKeistinenTHigh hospital burden in overlap syndrome of asthma and COPDClin Respir J2013734234623362945
  • SuzukiTTadaYKawataNClinical, physiological and radiological features of asthma-chronic obstructive pulmonary disease syndromeInt J Chron Obstruct Pulmon Dis20151094795426028967
  • LavoriniFFontanaGAUsmaniOSNew inhaler devices – the good, the bad and the uglyRespiration201488131524902629
  • PerngW-GHuangH-YChenH-MLeeY-CPerngR-PCharacteristics of airway inflammation and bronchodilator reversibility in COPD. A potential guide to treatmentChest2004126237538115302720
  • HaahtelaTVidgrenMNybergAKorhonenPLaurikainenKSilvastiMA novel multiple dose powder inhaler. Salbutamol powder and aerosol give equal bronchodilatation with equal dosesAnn Allergy19947221781828109809
  • SilvastiMLaurikainenKNieminenMSingle dose comparison between a novel multiple dose powder inhaler and a conventional metered dose inhaler in asthmatic patientsActa Ther Res199319125135
  • NieminenMVidgrenMLaurikainenKEasyhaler®, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to useRespiration199461137418177971
  • TammivaaraRAaltoELehtonenKComparison of a novel salbutamol multidose powder inhaler with a salbutamol metered dose inhaler in patients with asthmaCurr Ther Res19975810734744
  • GuyattGHTownsendMNogradiSPugsleySOKellerJLNewhouseMTAcute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitationAnn Intern Med1988148919491952
  • BrandPLQuanjerPHPostmaDSInterpretation of bronchodilator response in patients with obstructive airways diseaseThorax19924764294361496502
  • TanWCVollmerWMLamprechtBWorldwide pattern of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease studyThorax201267871872622544896
  • PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
  • AlbertPAgustiAEdwardsLBronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary diseaseThorax201267870170822696176
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
  • IPPB Trial GroupIntermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. A clinical trialAnn Intern Med1985995612620
  • CelliBRMacNeeWStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
  • JanssensJPPacheJCNicodLPPhysiological changes in respiratory function associated with ageingEur Respir J19991319720510836348
  • PalanderAMattilaTKarhuMMuttonenEIn vitro comparison of three salbutamol-containing multidose dry powder inhalers. Buventol Easyhaler®, Inspiryl Turbuhaler®, and Ventoline DiskusClin Drug Invest20002012533
  • VidgrenMSilvastiMKorhonenPKinkelinAFrischerBSternKClinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamolArzneim.-Forsch/Drug Res19954544477893268
  • NewmanSPPitcairnGRAdkinDAVidgrenMTSilvastiMComparison of beclomethasone dipropionate delivery by Easyhaler® dry powder inhaler and pMDI plus large volume spacerJ Aerosol Med200114221722511681653
  • GálffyGMezeiGNémethGInhaler competence and patient satisfaction with Easyhaler: results of two real-life multicentre studies in asthma and COPDDrugs RD2013133215222
  • GinerJTorrejónMRamosAPatient preference in the choice of dry powder inhalersArch Bronconeumol200440310610914998473
  • BroedersMEACVinckenWCorbettaLOn behalf of the ADMIT Working GroupThe ADMIT series – Issues in Inhalation Therapy. 7. Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation techniquePrim Care Respir J201120333834321808941
  • VinckenWDekhuijzenRBarnesPOn behalf of the ADMIT groupThe ADMIT series – Issues in Inhalation Therapy. 4. How to choose inhaler devices for the treatment of COPDPrim Care Respir J2010193102019890594
  • LavoriniFFontanaGAInhaler technique and patient’s preference for dry powder inhaler devicesExpert Opin Drug Deliv20141111324093806
  • MüllerVGálffyGEszesNAsthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized dose metered dose inhaler extrafine formulationBMC Pulm Med20111114021762500